Paris, France

Olivier Courtin

This inventor holds 4 USPTO granted patents. Top assignee: Aventis Pharma S.a.. Active years: 2004-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olivier Courtin. Retrieved from https://idiyas.com/inventor/olivier-courtin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 25.0

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2004-2007

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Olivier Courtin: Innovator in Antifungal Solutions

Introduction: Olivier Courtin is a distinguished inventor based in Paris, France, recognized for his significant contributions to the field of antifungal agents. With a total of four patents to his name, Courtin’s work has been instrumental in developing innovative solutions that address critical healthcare challenges.

Latest Patents: Among his latest achievements, Courtin has focused on Echinocandin derivatives and their applications. His patents cover compounds of formulas that incorporate specific substituents designed for efficacy as antifungal agents. These innovative derivatives are significant for their potential use in treating fungal infections, showcasing Courtin's dedication to advancing medical science through his inventions.

Career Highlights: Olivier Courtin is currently employed at Aventis Pharma S.A., a prominent pharmaceutical company where he leverages his expertise in drug discovery and development. His impressive portfolio reflects a commitment to innovation in the pharmaceutical sector, particularly in the area of antifungal therapies.

Collaborations: Throughout his career, Courtin has collaborated with notable colleagues, including Dominique Melon Manguer and Laurent Schio. These collaborations highlight the collaborative nature of scientific research, where ideas and expertise come together to foster innovation.

Conclusion: Olivier Courtin stands out as a significant contributor to pharmaceutical innovations, particularly in developing antifungal agents. With his ongoing efforts and collaborations at Aventis Pharma S.A., he continues to impact the medical field positively, paving the way for new and effective treatments. His work exemplifies the essence of innovation in addressing global health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…